Paper · 2026 · Open access
Nanocrystals: For Solubility Enhancement of Hydrophobic Drug
Zenodo (CERN European Organization for Nuclear Research) · Published 11 January 2026 · DOI 10.5281/zenodo.18213492
In brief
“Nanocrystals: For Solubility Enhancement of Hydrophobic Drug” is a 2026 paper by Vaishnavi Shelke*, Madhuri Narode, Pratiksha Pawar, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
The oral administration of numerous therapeutic compounds is frequently hindered by their limited solubility in water, which results in poor and inconsistent bioavailability. Drugs belonging to Biopharmaceutical Classification System (BCS) Class II demonstrate good membrane permeability but inadequate solubility, making dissolution the key step controlling absorption. To address this limitation, several formulation strategies have been explored, among which nanocrystal technology has gained considerable attention as an efficient and straightforward approach for improving dissolution behavior and solubility. Drug nanocrystals, consisting of pure drug particles typically below 1 µm in size, provide a greatly increased surface area that enhances saturation solubility and accelerates dissolution. Consequently, nanocrystals contribute to better bioavailability, reduced dose variation, and facilitate diverse administration routes such as oral, parenteral, and topical delivery. This review summarizes the underlying principles, advantages, and preparation techniques of nanocrystals including top-down, bottom-up, and hybrid methods along with recent advancements in nanocrystal-based systems for enhancing the performance of poorly soluble drugs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pawar, V. S. M. N. P. (2026). Nanocrystals: For Solubility Enhancement of Hydrophobic Drug. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18213492
MLA 9
Pawar, Vaishnavi Shelke*, Madhuri Narode, Pratiksha. “Nanocrystals: For Solubility Enhancement of Hydrophobic Drug.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.18213492.
Chicago
Pawar, Vaishnavi Shelke*, Madhuri Narode, Pratiksha. 2026. “Nanocrystals: For Solubility Enhancement of Hydrophobic Drug.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18213492.
Harvard
Pawar, V. S. M. N. P. (2026) ‘Nanocrystals: For Solubility Enhancement of Hydrophobic Drug’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.18213492.
IEEE
V. S. M. N. P. Pawar, “Nanocrystals: For Solubility Enhancement of Hydrophobic Drug,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.18213492.
BibTeX
@article{pawar2026nanocrystals,
title = {{Nanocrystals: For Solubility Enhancement of Hydrophobic Drug}},
author = {Pawar, Vaishnavi Shelke*, Madhuri Narode, Pratiksha},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.18213492},
url = {https://doi.org/10.5281/zenodo.18213492}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- drug nanocrystals
- solubility enhancement
- poorly water-soluble drugs
- BCS class II drugs
- oral bioavailability
- dissolution rate
- top-down and bottom-up synthesis
- hybrid synthesis
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Pawar, V. S. M. N. P. (2026). Nanocrystals: For Solubility Enhancement of Hydrophobic Drug. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18213492
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).
Who wrote this paper?
Vaishnavi Shelke*, Madhuri Narode, Pratiksha Pawar.
What is the DOI of this paper?
10.5281/zenodo.18213492. The permanent link is https://doi.org/10.5281/zenodo.18213492.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.